trinitrate transdermal patch appear to be a safe, well tolerated, and noninvasive method of suppressing uterine contractions in preterm labor.
With the topical use of glyceryl
trinitrate ointment, patients can be managed on out patients basis.
(Table III) Poor tolerance and poor compliance with treatment were important factors in patients whose fissures did not heal with glyceryl
Intensive Shea Body Butter AAK +46 454 82000 E-mail: email@example.com Website: www.aakpersonalcare.com INGREDIENTS WT% Phase A Emulgade PL 68/50 (BASF) 7.00 (Cetearyl glucoside (and) cetearyl alcohol) Glyceryl
stearate 4.00 Lanette E granules (BASF) 1.00 (Sodium cetearyl sulfate) Lipex Sheasoft (AAK) 15.00 (Butyrospermum parkii (shea) butter) Lipex SheaLight (AAK) (Shea butter ethyl esters) 5.00 Lipex 205 (AAK) (Butyrospermum parkii (shea) butter) 3.00 Lipex L'Sens (AAK) (Soybean glycerides (and) 3.00 butyrospermum parkii (shea) butter unsaponifiables) Phase B Water q.s.
dipalmitate (and) glyceryl
distearate (and) glyceryl
www.lipochemicals.com INGREDIENTS WT% Phase A Deionized water 62.40 Disodium EDTA (Ruger Chemical) 0.10 Veegum HV (Vandcrbilt) (Magnesium aluminum 1.00 silicate) Phase B Xanthan gum (Ruger Chemical) 0.50 Liponic EG-1 (Lipo Chemicals) (Glycereth-26) 4.00 Phase C Lipomulse 165 (Lipo Chemicals) (Glyceryl
4.00 stearate (and) PEG-100 stearate) 4.00 Lipo GMS 450 VEG (Glyceryl
stearate) 2.00 Liponate GC (Lipo Chemicals) (Caprylic/capric 8.00 triglyceride) Lipobutter Refined Shea (Lipo Chemicals) 5.00 (Butyrospermum parkii (Shea butter)) Lipocol SC (Lipo Chemicals) (Cetearyl 2.00 alcohol) Phase D Kaolin (Ruger Chemical) 10.00 Phase E Vedaplex 121 NF (Lipo (SIR Biotech India)) 1.00 (Limon (lemon) peel powder (and) Citrus q.s.
ethers into the polar head of phospholipids in the presence of a food-grade phospholipase D makes it possible to obtain new bioactive ingredients.
The rationale of doing the study is, to compare the effectiveness of 0.2% glyceryl
trinitrate ointment with surgical sphincterotomy.
has been awarded a patent for a foaming antimicrobial dermal cleanser comprising a cationic active ingredient; a cationic compatible surfactant, wherein the cationic compatible surfactant is an alkyl amine oxide and/or an alkyl ether amine oxide; a foam boosting agent selected from the group consisting of glyceryl
caprylate/caprate, sorbitan sesquicaprylate, phospholipids, polyethylene glycol dimethicone with methylesters, polyethylene glycol-7 glyceryl
cocoate, capris/caprylic monoglycerides, hydrophobically-modified cationic polymers, and combinations thereof; a foam structure enhancing agent; a skin conditioning agent; and water.